Oral cannabis induces psychosis at low levels
Key points
- Even in clinical situations where cannabis is administered orally at low doses, psychotic reactions can occur, Swiss researchers report the current issue of BMC Psychiatry.
- Recreational cannabis use has been associated with psychotic reactions, but this is the first such report in closely monitored subjects participating in a clinical trial, note Dr.
- Favrat's group was conducting a study to examine the effects of ingestion of THC (delta-9-tetrahydrocannabinol) on psychomotor function and driving performance in eight occasional cannabis users.
- The first case of psychosis was in a 22-year-old man given 20 milligrams of dronabinol, a synthetic THC.
Even in clinical situations where cannabis is administered orally at low doses, psychotic reactions can occur, Swiss researchers report the current issue of BMC Psychiatry.
Recreational cannabis use has been associated with psychotic reactions, but this is the first such report in closely monitored subjects participating in a clinical trial, note Dr. Bernard Favrat and colleagues at Institut Universitaire de Medicine Legale in Lausanne.
Favrat's group was conducting a study to examine the effects of ingestion of THC (delta-9-tetrahydrocannabinol) on psychomotor function and driving performance in eight occasional cannabis users.
The first case of psychosis was in a 22-year-old man given 20 milligrams of dronabinol, a synthetic THC. Ninety minutes after dronabinol administration he experienced severe anxiety and symptoms of psychosis, and was unable to perform the two psychometric tests.
Levels of THC and its active metabolite 11-OH-THC in the blood at the time of the strong adverse effects were 1.8 and 5.2 nanograms per milliliter, respectively.
The second case was also a 22-year-old man who developed severe anxiety one hour after taking 16.5 milligrams of a THC compound, when his THC blood level was 6.2 nanograms per milligram and 11-OH-THC was 3.9 nanograms per milligram. For several hours he was unable to perform psychometric tests
The authors note that Smoking a 3.5-percent marijuana cigarette leads to blood concentrations of THC in the range of 50 to 100 nanograms per milliliter. They believe that oral administration produces higher levels of 11-OH-THC, with slower elimination.
Alternatively, they suggest that "consuming oral cannabis may produce more potent, yet unknown psychotomimetic metabolites of THC."
"Doctors and users should be aware of the increasing availability of oral cannabis in 'special' drinks or food as well as in medications under development," which can result in "significant psychotic reactions," Favrat's group cautions.
SOURCE: BMC Psychiatry, April 1,2005.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Addiction →
NewsSecond-hand smoke levels still worryingly high throughout all areas of pubs
UK scientists have questioned the use of partial smoking bans in pubs and clubs, following alarming new figures about how much non-smokers actually breathe in. Researchers from an alliance of universities found that…
15 February 2006
NewsCannabis Almost Doubles Risk of Fatal Crashes
Driving under the influence of cannabis almost doubles the risk of a fatal road crash, finds a study published online by the BMJ today. However its share in fatal crashes is significantly lower than those involving…
5 December 2005
NewsUK's GW Pharma launches cannabis drug in Canada
GW Pharmaceuticals Plc's pioneering cannabis-based medicine has been launched in Canada, the British firm said on Monday. GW said its Sativex medicine was now available by prescription in Canada to treat pain in adults…
